Loading…

Pheochromocytoma and paraganglioma : Importance of diagnostic imaging

If pheochromocytoma (PC) or paraganglioma (PGL) is diagnosed based on serologic studies, imaging is required to locate the adrenal mass for further management. Besides pathognomonic hormonal findings, PC/PGL can exhibit typical imaging features. However, PC/PGL can also show morphological overlap wi...

Full description

Saved in:
Bibliographic Details
Published in:Radiologe 2019-11, Vol.59 (11), p.975-981
Main Authors: Kunz, W G, Auernhammer, C J, Nölting, S, Pfluger, T, Ricke, J, Cyran, C C
Format: Article
Language:ger
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 981
container_issue 11
container_start_page 975
container_title Radiologe
container_volume 59
creator Kunz, W G
Auernhammer, C J
Nölting, S
Pfluger, T
Ricke, J
Cyran, C C
description If pheochromocytoma (PC) or paraganglioma (PGL) is diagnosed based on serologic studies, imaging is required to locate the adrenal mass for further management. Besides pathognomonic hormonal findings, PC/PGL can exhibit typical imaging features. However, PC/PGL can also show morphological overlap with other pathologies. The modality of choice for evaluation of PC is CT. In case of extra-adrenal location, MRI is superior to CT. Imaging with PET-CT provides complementary information in the differentiation of PC/PGL and is recommended as the imaging modality of choice for malignant PC/PGL. Ga-DOTATATE (or Ga-DOTATOC/ Ga-DOTANOC) PET-CT has high sensitivity for SDHx-mutated PC/PGL and serves for planning of radioreceptor therapy with somatostatin analogues. In contrast, I-metaiodobenzylguanidine (MIBG) scintigraphy is important in assessing the potential efficacy of radioreceptor therapy with MIBG. The CT protocol for PC evaluation should include non-enhanced, arterial, portal-venous and late phases; the latter for the evaluation of wash-out. Recent studies indicate non-enhanced CT alone may be sufficient to rule out PC. For MRI, in- and opposed-phase sequences should be additionally acquired. A relevant proportion of PC is diagnosed incidentally. Therefore, imaging of PC will gain further importance. Recent studies show better response rates of PC/PGL after radioreceptor therapy with somatostatin analogues ( Lu-DOTATATE) than with MIBG. Therefore, Ga-DOTATATE PET-CT gains further importance-for diagnostic imaging and therapy planning.
doi_str_mv 10.1007/s00117-019-0569-7
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2263321678</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2263321678</sourcerecordid><originalsourceid>FETCH-LOGICAL-p141t-2bde1b8300c609b4faa4654ffbde41e9a6120b14badc6d9be57ba733fbb91f5a3</originalsourceid><addsrcrecordid>eNo1j0FLwzAYhoMgbk5_gBfp0Us0X5KmjTcZUwcDPei5fEmTrtI2NekO-_dWnKcXHh5e3peQG2D3wFjxkBgDKCgDTVmuNC3OyBKk4JQD4wtymdLXbHDN9QVZCBCizHm5JJv3vQt2H0Mf7HEKPWY41NmIERscmq79JY_Zth9DnHCwLgs-q1tshpCm1mZtj007NFfk3GOX3PUpV-TzefOxfqW7t5ft-mlHR5AwUW5qB6YUjFnFtJEeUapcej9zCU6jAs4MSIO1VbU2Li8MFkJ4YzT4HMWK3P31jjF8H1yaqr5N1nUdDi4cUsW5EoKDKspZvT2pB9O7uhrjvDUeq__r4gfsXlpn</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2263321678</pqid></control><display><type>article</type><title>Pheochromocytoma and paraganglioma : Importance of diagnostic imaging</title><source>Alma/SFX Local Collection</source><creator>Kunz, W G ; Auernhammer, C J ; Nölting, S ; Pfluger, T ; Ricke, J ; Cyran, C C</creator><creatorcontrib>Kunz, W G ; Auernhammer, C J ; Nölting, S ; Pfluger, T ; Ricke, J ; Cyran, C C</creatorcontrib><description>If pheochromocytoma (PC) or paraganglioma (PGL) is diagnosed based on serologic studies, imaging is required to locate the adrenal mass for further management. Besides pathognomonic hormonal findings, PC/PGL can exhibit typical imaging features. However, PC/PGL can also show morphological overlap with other pathologies. The modality of choice for evaluation of PC is CT. In case of extra-adrenal location, MRI is superior to CT. Imaging with PET-CT provides complementary information in the differentiation of PC/PGL and is recommended as the imaging modality of choice for malignant PC/PGL. Ga-DOTATATE (or Ga-DOTATOC/ Ga-DOTANOC) PET-CT has high sensitivity for SDHx-mutated PC/PGL and serves for planning of radioreceptor therapy with somatostatin analogues. In contrast, I-metaiodobenzylguanidine (MIBG) scintigraphy is important in assessing the potential efficacy of radioreceptor therapy with MIBG. The CT protocol for PC evaluation should include non-enhanced, arterial, portal-venous and late phases; the latter for the evaluation of wash-out. Recent studies indicate non-enhanced CT alone may be sufficient to rule out PC. For MRI, in- and opposed-phase sequences should be additionally acquired. A relevant proportion of PC is diagnosed incidentally. Therefore, imaging of PC will gain further importance. Recent studies show better response rates of PC/PGL after radioreceptor therapy with somatostatin analogues ( Lu-DOTATATE) than with MIBG. Therefore, Ga-DOTATATE PET-CT gains further importance-for diagnostic imaging and therapy planning.</description><identifier>EISSN: 1432-2102</identifier><identifier>DOI: 10.1007/s00117-019-0569-7</identifier><identifier>PMID: 31338528</identifier><language>ger</language><publisher>Germany</publisher><subject>Adrenal Gland Neoplasms - diagnostic imaging ; Diagnosis, Differential ; Humans ; Paraganglioma - diagnostic imaging ; Pheochromocytoma - diagnostic imaging ; Positron Emission Tomography Computed Tomography - methods ; Positron-Emission Tomography - methods</subject><ispartof>Radiologe, 2019-11, Vol.59 (11), p.975-981</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31338528$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kunz, W G</creatorcontrib><creatorcontrib>Auernhammer, C J</creatorcontrib><creatorcontrib>Nölting, S</creatorcontrib><creatorcontrib>Pfluger, T</creatorcontrib><creatorcontrib>Ricke, J</creatorcontrib><creatorcontrib>Cyran, C C</creatorcontrib><title>Pheochromocytoma and paraganglioma : Importance of diagnostic imaging</title><title>Radiologe</title><addtitle>Radiologe</addtitle><description>If pheochromocytoma (PC) or paraganglioma (PGL) is diagnosed based on serologic studies, imaging is required to locate the adrenal mass for further management. Besides pathognomonic hormonal findings, PC/PGL can exhibit typical imaging features. However, PC/PGL can also show morphological overlap with other pathologies. The modality of choice for evaluation of PC is CT. In case of extra-adrenal location, MRI is superior to CT. Imaging with PET-CT provides complementary information in the differentiation of PC/PGL and is recommended as the imaging modality of choice for malignant PC/PGL. Ga-DOTATATE (or Ga-DOTATOC/ Ga-DOTANOC) PET-CT has high sensitivity for SDHx-mutated PC/PGL and serves for planning of radioreceptor therapy with somatostatin analogues. In contrast, I-metaiodobenzylguanidine (MIBG) scintigraphy is important in assessing the potential efficacy of radioreceptor therapy with MIBG. The CT protocol for PC evaluation should include non-enhanced, arterial, portal-venous and late phases; the latter for the evaluation of wash-out. Recent studies indicate non-enhanced CT alone may be sufficient to rule out PC. For MRI, in- and opposed-phase sequences should be additionally acquired. A relevant proportion of PC is diagnosed incidentally. Therefore, imaging of PC will gain further importance. Recent studies show better response rates of PC/PGL after radioreceptor therapy with somatostatin analogues ( Lu-DOTATATE) than with MIBG. Therefore, Ga-DOTATATE PET-CT gains further importance-for diagnostic imaging and therapy planning.</description><subject>Adrenal Gland Neoplasms - diagnostic imaging</subject><subject>Diagnosis, Differential</subject><subject>Humans</subject><subject>Paraganglioma - diagnostic imaging</subject><subject>Pheochromocytoma - diagnostic imaging</subject><subject>Positron Emission Tomography Computed Tomography - methods</subject><subject>Positron-Emission Tomography - methods</subject><issn>1432-2102</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNo1j0FLwzAYhoMgbk5_gBfp0Us0X5KmjTcZUwcDPei5fEmTrtI2NekO-_dWnKcXHh5e3peQG2D3wFjxkBgDKCgDTVmuNC3OyBKk4JQD4wtymdLXbHDN9QVZCBCizHm5JJv3vQt2H0Mf7HEKPWY41NmIERscmq79JY_Zth9DnHCwLgs-q1tshpCm1mZtj007NFfk3GOX3PUpV-TzefOxfqW7t5ft-mlHR5AwUW5qB6YUjFnFtJEeUapcej9zCU6jAs4MSIO1VbU2Li8MFkJ4YzT4HMWK3P31jjF8H1yaqr5N1nUdDi4cUsW5EoKDKspZvT2pB9O7uhrjvDUeq__r4gfsXlpn</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>Kunz, W G</creator><creator>Auernhammer, C J</creator><creator>Nölting, S</creator><creator>Pfluger, T</creator><creator>Ricke, J</creator><creator>Cyran, C C</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201911</creationdate><title>Pheochromocytoma and paraganglioma : Importance of diagnostic imaging</title><author>Kunz, W G ; Auernhammer, C J ; Nölting, S ; Pfluger, T ; Ricke, J ; Cyran, C C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p141t-2bde1b8300c609b4faa4654ffbde41e9a6120b14badc6d9be57ba733fbb91f5a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2019</creationdate><topic>Adrenal Gland Neoplasms - diagnostic imaging</topic><topic>Diagnosis, Differential</topic><topic>Humans</topic><topic>Paraganglioma - diagnostic imaging</topic><topic>Pheochromocytoma - diagnostic imaging</topic><topic>Positron Emission Tomography Computed Tomography - methods</topic><topic>Positron-Emission Tomography - methods</topic><toplevel>online_resources</toplevel><creatorcontrib>Kunz, W G</creatorcontrib><creatorcontrib>Auernhammer, C J</creatorcontrib><creatorcontrib>Nölting, S</creatorcontrib><creatorcontrib>Pfluger, T</creatorcontrib><creatorcontrib>Ricke, J</creatorcontrib><creatorcontrib>Cyran, C C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Radiologe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kunz, W G</au><au>Auernhammer, C J</au><au>Nölting, S</au><au>Pfluger, T</au><au>Ricke, J</au><au>Cyran, C C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pheochromocytoma and paraganglioma : Importance of diagnostic imaging</atitle><jtitle>Radiologe</jtitle><addtitle>Radiologe</addtitle><date>2019-11</date><risdate>2019</risdate><volume>59</volume><issue>11</issue><spage>975</spage><epage>981</epage><pages>975-981</pages><eissn>1432-2102</eissn><abstract>If pheochromocytoma (PC) or paraganglioma (PGL) is diagnosed based on serologic studies, imaging is required to locate the adrenal mass for further management. Besides pathognomonic hormonal findings, PC/PGL can exhibit typical imaging features. However, PC/PGL can also show morphological overlap with other pathologies. The modality of choice for evaluation of PC is CT. In case of extra-adrenal location, MRI is superior to CT. Imaging with PET-CT provides complementary information in the differentiation of PC/PGL and is recommended as the imaging modality of choice for malignant PC/PGL. Ga-DOTATATE (or Ga-DOTATOC/ Ga-DOTANOC) PET-CT has high sensitivity for SDHx-mutated PC/PGL and serves for planning of radioreceptor therapy with somatostatin analogues. In contrast, I-metaiodobenzylguanidine (MIBG) scintigraphy is important in assessing the potential efficacy of radioreceptor therapy with MIBG. The CT protocol for PC evaluation should include non-enhanced, arterial, portal-venous and late phases; the latter for the evaluation of wash-out. Recent studies indicate non-enhanced CT alone may be sufficient to rule out PC. For MRI, in- and opposed-phase sequences should be additionally acquired. A relevant proportion of PC is diagnosed incidentally. Therefore, imaging of PC will gain further importance. Recent studies show better response rates of PC/PGL after radioreceptor therapy with somatostatin analogues ( Lu-DOTATATE) than with MIBG. Therefore, Ga-DOTATATE PET-CT gains further importance-for diagnostic imaging and therapy planning.</abstract><cop>Germany</cop><pmid>31338528</pmid><doi>10.1007/s00117-019-0569-7</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier EISSN: 1432-2102
ispartof Radiologe, 2019-11, Vol.59 (11), p.975-981
issn 1432-2102
language ger
recordid cdi_proquest_miscellaneous_2263321678
source Alma/SFX Local Collection
subjects Adrenal Gland Neoplasms - diagnostic imaging
Diagnosis, Differential
Humans
Paraganglioma - diagnostic imaging
Pheochromocytoma - diagnostic imaging
Positron Emission Tomography Computed Tomography - methods
Positron-Emission Tomography - methods
title Pheochromocytoma and paraganglioma : Importance of diagnostic imaging
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A31%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pheochromocytoma%20and%20paraganglioma%20:%20Importance%20of%20diagnostic%20imaging&rft.jtitle=Radiologe&rft.au=Kunz,%20W%20G&rft.date=2019-11&rft.volume=59&rft.issue=11&rft.spage=975&rft.epage=981&rft.pages=975-981&rft.eissn=1432-2102&rft_id=info:doi/10.1007/s00117-019-0569-7&rft_dat=%3Cproquest_pubme%3E2263321678%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p141t-2bde1b8300c609b4faa4654ffbde41e9a6120b14badc6d9be57ba733fbb91f5a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2263321678&rft_id=info:pmid/31338528&rfr_iscdi=true